MedTrace Logo

Transmitted Light Tissue Thickness Analysis (TiLTT)

NCT02749201 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2021-06-23

Study results available
· View outcomes & findings →

Summary

To assess gastric wall thickness using transmitted light intensity.

Conditions

  • Morbid Obesity

Interventions

DEVICE

Gastrisail

Light Intensity and gastric wall thickness assessment

Sponsors & Collaborators

  • Medtronic

    collaborator INDUSTRY

  • Maimonides Medical Center

    lead OTHER

Principal Investigators

  • Danny Sherwinter, MD · Maimonides Medical Center

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-04-30
Primary Completion
2017-04-30
Completion
2017-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02749201 on ClinicalTrials.gov